Solicitation
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
BAA-23-100-SOL-00004
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
$3,784,396.00 obligated so far on USAspending
Description
As published on SAM.gov.
We appreciate your interest in partnering with BARDA. The latest BARDA Broad Agency Announcement (BAA) is Amendment 7 posted on March 19, 2026. All contracting-related inquiries should be sent to BARDA-BAA@hhs.gov. The final proposal submission deadline is September 25, 2028, at 4:30 PM Eastern Time for open areas of interest.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Kaleo, Inc.
- UEI
- LBM4GLJNDK31
- CAGE
- 5LVP8
- Vendor location
- Richmond, VA
- Contract
- 75A50124C00010, definitive contract
- Obligated
- $3,784,396.00, current value $33,258,615, potential $33,762,976
- Actions
- 1 between March 16, 2026 and March 16, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Development of a Novel Pralidoxime Chloride Auto-Injector Device
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
- Recipient
- Cerus Corporation
- UEI
- KJJQRRLY2FL5
- CAGE
- 1PVJ6
- Vendor location
- Concord, CA
- Contract
- 75A50124C00046, definitive contract
- Obligated
- $33,237,041.00, current value $65,358,564, potential $209,038,158
- Actions
- 1 between July 21, 2026 and July 21, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Supplemental Funding to the Base Period (Clin 0001, Clin 0002 & Clin 0003); Exercise Option 1 (Clin 0004); Update Travel Budget; Update Go/No-Go Milestones; Update Indirect Rates; Update Coa Threshold to $350,000; Incorporate Mandatory Clauses as
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
- Recipient
- Gigagen Inc.
- UEI
- HF7MJJDVQQX5
- CAGE
- 626U9
- Vendor location
- San Carlos, CA
- Contract
- 75A50124C00049, definitive contract
- Obligated
- $0.00, current value $19,633,227, potential $135,212,671
- Actions
- 2 between February 6, 2026 and September 3, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- The Purpose of This No Cost Modification Is to Change the Cor from Saima Zaman to Annie XI Lu and Add Saima Zaman as the Alt Cor
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
- Recipient
- 4J Therapeutics Inc.
- UEI
- SZCGV7LQJKR4
- CAGE
- 9DFF0
- Vendor location
- Palo Alto, CA
- Contract
- 75A50124C00052, definitive contract
- Obligated
- $14,894,558.00, current value $52,484,360, potential $351,633,257
- Actions
- 1 between August 21, 2026 and August 21, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- The Purpose of This Modification Is to Update Article B.3 Estimated Cost-Plus Fixed Fee Clins, Establish Clins 3A (Option Period 2A) and Clin 3B (Option Period 2B), Exercise Option 3A, and Update Section J - List of Attachments, Attachment #1, Statem
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
- Recipient
- Orexo US Inc.
- UEI
- MN1MPMBCVVD5
- CAGE
- 6Y7L3
- Vendor location
- Morristown, NJ
- Contract
- 75A50125C00010, definitive contract
- Obligated
- $2,999,997.00, current value $11,450,712, potential $53,897,252
- Actions
- 1 between September 4, 2026 and September 4, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Add Supplemental Funding to Clin 0001 & 0002, Extend Pop to 12/31/2027 for Clin 0001 & 0002, Update Key Personnel, Update Sow, Update FAR & Hhsar Clauses
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
- Recipient
- Rafa Laboratories Ltd.
- UEI
- CKDNTKNDPMJ6
- CAGE
- 0905A
- Vendor location
- Jerusalem
- Contract
- 75A50125C00018, definitive contract
- Obligated
- $230,350.00, current value $11,997,762, potential $147,733,954
- Actions
- 1 between August 10, 2026 and August 10, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- The Scope of Work for This Contract Includes the Following Development Essentials: CMC Development, Pre-Clinical and Clinical Studies, Device Development Activities, Human Factors Testing, Market Viability Assessments Along with All Associated Regula
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
- Recipient
- Flosonics Medical LLC
- UEI
- RD81CL8M8EM9
- CAGE
- 9UH24
- Vendor location
- Mountain View, CA
- Contract
- 75A50126C00006, definitive contract
- Obligated
- $15,002,035.00, potential $69,809,569
- Actions
- 1 between June 5, 2026 and June 5, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- The Purpose of This Contract Is to Advance the Development of Flopatch FP120 with Flopredict Alert for Burn and Blast Medical Countermeasure and Incorporates Eo 14398.
- Match
- solicitation number BAA23100SOL00004 equals the FPDS solicitation identifier; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- BARDA-BAA@hhs.govBARDA-BAA@hhs.gov
Also open from this buyer
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseSolicitationNAICS 541714District of Columbia75A50126R00001_RFP_NPIVS_27Closes in 65 daysNov 20